Author

PHILIP R. WYATT

Observed names: P Wyatt, PHILIP WYATT, Philip R Wyatt, Philip R. Wyatt, Philip Wyatt

Institution: Exemplar Genetics (United States)

Observed institutions: Mount Sinai Hospital, Sunnybrook Health Science Centre, Mount Sinai Hospital, University of Kentucky, University of Toronto, York Central Hospital, North York General Hospital, Albert B. Chandler Hospital, LabCorp (United States), Deer Lodge Centre, Sequenom (United States), Exemplar Genetics (United States), Soldiers' Memorial Hospital, University of Manitoba

OpenAlex ID: A5109046477

RETIRED: Pregnancy Outcomes After Assisted Reproductive Technology

2006 · Victoria M. Allen, R. Douglas Wilson, et al. · Journal of Obstetrics and Gynaecology Canada · 337

Association of neural tube defects and folic acid food fortification in Canada

2002 · Joel G Ray, Chris Meier, et al. · The Lancet · 294

RETIRED: Pre-conceptional Vitamin/Folic Acid Supplementation 2007: The Use of Folic Acid in Combination With a Multivitamin Supplement for the Prevention of Neural Tube Defects and Other Congenital Anomalies

2007 · R. Douglas Wilson, R. Douglas Wilson, et al. · Journal of Obstetrics and Gynaecology Canada · 288

RETIRED: Obstetrical Complications Associated With Abnormal Maternal Serum Markers Analytes

2008 · Alain Gagnon, R. Douglas Wilson, et al. · Journal of Obstetrics and Gynaecology Canada · 281

The Use of Folic Acid for the Prevention of Neural Tube Defects and Other Congenital Anomalies

2003 · R Douglas Wilson, Gregory Davies, et al. · Journal of Obstetrics and Gynaecology Canada · 204

Rare Trisomy Mosaicism Diagnosed in Amniocytes, Involving an Autosome Other Than Chromosomes 13, 18, 20, and 21: Karyotype/phenotype Correlations

1997 · LILLIAN Y. F. HSU, MING-TSUNG YU, et al. · Prenatal Diagnosis · 204

Vitamin B12 and the Risk of Neural Tube Defects in a Folic-Acid-Fortified Population

2007 · Joel G. Ray, Philip R. Wyatt, et al. · Epidemiology · 203

Greater Maternal Weight and the Ongoing Risk of Neural Tube Defects After Folic Acid Flour Fortification

2005 · Joel G. Ray, Philip R. Wyatt, et al. · Obstetrics and Gynecology · 150

Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin

1995 · Glenn E. Palomaki, James E. Haddow, et al. · Prenatal Diagnosis · 140

RETIRED: Teratogenicity Associated With Pre-Existing and Gestational Diabete

2007 · Victoria M. Allen, B. Anthony Armson, et al. · Journal of Obstetrics and Gynaecology Canada · 125

Age-specific risk of fetal loss observed in a second trimester serum screening population

2005 · Philip R. Wyatt, Titus Owolabi, et al. · American Journal of Obstetrics and Gynecology · 114

RETIRED: Prevention of Rh Alloimmunization

2003 · Karen Fung Kee Fung, Erica Eason, et al. · Journal of Obstetrics and Gynaecology Canada · 110

Investigation ofNRXN1deletions: Clinical and molecular characterization

2013 · Mindy Preston Dabell, Jill A. Rosenfeld, et al. · American Journal of Medical Genetics Part A · 108

PDF

Carrier Screening for Thalassemia and Hemoglobinopathies in Canada

2008 · Sylvie Langlois, Jason C. Ford, et al. · Journal of Obstetrics and Gynaecology Canada · 98

RETIRED: Evaluation of Prenatally Diagnosed Structural Congenital Anomalies

2009 · Alain Gagnon, R. Douglas Wilson, et al. · Journal of Obstetrics and Gynaecology Canada · 89

Prevalence of trisomy 21 following folic acid food fortification

2003 · Joel G. Ray, Chris Meier, et al. · American Journal of Medical Genetics Part A · 65

Association between folic acid food fortification and congenital orofacial clefts

2003 · Joel G Ray, Chris Meier, et al. · The Journal of Pediatrics · 62

Metabolic Syndrome features and risk of neural tube defects

2007 · Joel G Ray, Miles D Thompson, et al. · BMC Pregnancy and Childbirth · 41

PDF

Ultrasound detection of placental insufficiency in women with ‘unexplained’ abnormal maternal serum screening results

2005 · W Whittle, V Chaddha, et al. · Clinical Genetics · 41

RETIRED: Mid-Trimester Amniocentesis Fetal Loss Rate

2007 · R. Douglas Wilson, Sylvie Langlois, et al. · Journal of Obstetrics and Gynaecology Canada · 36

Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes

2002 · David Chitayat, Sandra A. Farrell, et al. · American Journal of Obstetrics and Gynecology · 35

Cytogenetic aspects of the Canadian early and mid-trimester amniotic fluid trial (CEMAT)

1999 · Elizabeth J. T. Winsor, Darrell J. Tomkins, et al. · Prenatal Diagnosis · 32

Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR)

2017 · Matthew S. Lebo, Kathleen-Rose Zakoor, et al. · Genetics in Medicine · 31

PDF

The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening

2005 · Tianhua Huang, Titus Owolabi, et al. · American Journal of Obstetrics and Gynecology · 22

RETIRED: Fragile X Testing in Obstetrics and Gynaecology in Canada

2008 · David Chitayat, Philip R. Wyatt, et al. · Journal of Obstetrics and Gynaecology Canada · 20

Works count: 76

Citation count: 3,437

H-index: 23

I10-index: 40